1. Home
  2. NVO vs JNJ Comparison

NVO vs JNJ Comparison

Compare NVO & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novo Nordisk A/S

NVO

Novo Nordisk A/S

HOLD

Current Price

$43.04

Market Cap

197.4B

Sector

Health Care

ML Signal

HOLD

Logo Johnson & Johnson

JNJ

Johnson & Johnson

HOLD

Current Price

$232.77

Market Cap

542.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVO
JNJ
Founded
1923
1886
Country
Denmark
United States
Employees
69500
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
197.4B
542.4B
IPO Year
N/A
2003

Fundamental Metrics

Financial Performance
Metric
NVO
JNJ
Price
$43.04
$232.77
Analyst Decision
Hold
Buy
Analyst Count
11
20
Target Price
$51.00
$238.20
AVG Volume (30 Days)
10.9M
5.9M
Earning Date
05-06-2026
04-14-2026
Dividend Yield
3.19%
2.36%
EPS Growth
N/A
90.50
EPS
N/A
2.14
Revenue
N/A
N/A
Revenue This Year
N/A
$6.63
Revenue Next Year
$3.70
$7.43
P/E Ratio
$13.60
$106.65
Revenue Growth
N/A
N/A
52 Week Low
$35.12
$149.04
52 Week High
$81.44
$251.71

Technical Indicators

Market Signals
Indicator
NVO
JNJ
Relative Strength Index (RSI) 46.75 57.14
Support Level $35.49 $222.07
Resistance Level $50.30 $235.50
Average True Range (ATR) 1.15 3.84
MACD -0.45 0.26
Stochastic Oscillator 27.11 83.66

Price Performance

Historical Comparison
NVO
JNJ

About NVO Novo Nordisk A/S

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (contributing less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.

About JNJ Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Share on Social Networks: